Indeed, dysregulation of RAVER1 and RBM3 has been recently related with the development of non-alcoholic fatty liver disease [58], while RAVER1 has been found to be dysregulated in patients with cardiovascular disease at higher risk of type-2 diabetes development [59]. This evidence concerns the gene RAVER1 and metabolic dysfunction-associated steatotic liver disease.